{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:42:44Z","timestamp":1790714564202,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ejps.2020.105323","type":"journal-article","created":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T01:59:48Z","timestamp":1585965588000},"page":"105323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Ebselen nanoemulgel for the treatment of topical fungal infection"],"prefix":"10.1016","volume":"148","author":[{"given":"Richa","family":"Vartak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvidha","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Patki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blase","family":"Billack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8252-0234","authenticated-orcid":false,"given":"Ketan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejps.2020.105323_bib0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ph12010015","article-title":"Micellisation mechanism and behaviour of soluplus(r)(-)furosemide micelles: preformulation studies of an oral nanocarrier-based system","volume":"12","author":"Alopaeus","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejps.2020.105323_bib0002","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1007\/s11033-014-3417-x","article-title":"Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways","volume":"41","author":"Azad","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejps.2020.105323_bib0003","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3109\/14756360903179419","article-title":"Evaluation of the antifungal and plasma membrane H+-ATPase inhibitory action of Ebselen and two Ebselen analogs in s. cerevisiae cultures.","volume":"25","author":"Billack","year":"2010","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejps.2020.105323_bib0004","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/mdr.2009.0872","article-title":"Growth inhibitory action of Ebselen on fluconazole-resistant candida albicans: role of the plasma membrane H+-ATPase","volume":"15","author":"Billack","year":"2009","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.ejps.2020.105323_bib0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2015.04.059","article-title":"Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers","volume":"489","author":"Boakye","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105323_bib0006","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1590\/S1806-83242009000300006","article-title":"A simple method to measure cell viability in proliferation and cytotoxicity assays","volume":"23","author":"Borra","year":"2009","journal-title":"Braz. Oral. Res."},{"key":"10.1016\/j.ejps.2020.105323_bib0007","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2478\/acph-2013-0040","article-title":"Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs","volume":"63","author":"\u010cerpnjak","year":"2013","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejps.2020.105323_bib0008","first-page":"2250","article-title":"Nanoemulsion and nanoemulgel as a topical formulation","volume":"5","author":"Chellapa","year":"2015","journal-title":"IOSR J. Pharm."},{"key":"10.1016\/j.ejps.2020.105323_bib0009","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2217\/nnm.10.126","article-title":"Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances","volume":"5","author":"Date","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejps.2020.105323_bib0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/2230-973X.133053","article-title":"Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation","volume":"4","author":"Dhawan","year":"2014","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.ejps.2020.105323_bib0011","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4155\/tde.14.61","article-title":"Delivery and targeting of nanoparticles into hair follicles","volume":"5","author":"Fang","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejps.2020.105323_bib0012","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.mib.2011.06.001","article-title":"Mucosal biofilms of candida albicans","volume":"14","author":"Ganguly","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejps.2020.105323_bib0013","first-page":"358","article-title":"Preparation and solid state characterization of nanocrystals for solubility enhancement of quetiapine fumarate","volume":"6","author":"Gubbala","year":"2014","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105323_bib0014","article-title":"Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems","volume":"2013","author":"Gupta","year":"2013","journal-title":"ISRN Pharm."},{"key":"10.1016\/j.ejps.2020.105323_bib0015","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijpharm.2018.06.012","article-title":"Strat-M\u00ae synthetic membrane: permeability comparison to human cadaver skin","volume":"547","author":"Haq","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105323_bib0016","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4172\/pharmaceutical-sciences.1000353","article-title":"Topical nanoemmigel formulation of boswellia serrata","volume":"80","author":"Harsha","year":"2018","journal-title":"Indian J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejps.2020.105323_bib0017","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","article-title":"Epidemiological trends in skin mycoses worldwide","volume":"51","author":"Havlickova","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.ejps.2020.105323_bib0018","series-title":"Fungal Disease in Britain and the United States 1850-2000: Mycoses and Modernity","author":"Homei","year":"2013"},{"key":"10.1016\/j.ejps.2020.105323_bib0019","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2217\/nnm-2017-0337","article-title":"Topical delivery of Ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity","volume":"13","author":"Jaromin","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejps.2020.105323_bib0020","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.apsb.2015.07.003","article-title":"Insoluble drug delivery strategies: review of recent advances and business prospects","volume":"5","author":"Kalepu","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejps.2020.105323_bib0021","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.molliq.2016.02.081","article-title":"Self-nanoemulsifying drug delivery system (SNEDDS) with enhanced solubilization of nystatin for treatment of oral candidiasis: design, optimization, in vitro and in vivo evaluation","volume":"218","author":"Kassem","year":"2016","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejps.2020.105323_bib0022","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3109\/10717544.2013.878003","article-title":"Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid naringenin: design, characterization, in vitro and in vivo evaluation","volume":"22","author":"Khan","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2020.105323_bib0023","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.mycmed.2018.02.004","article-title":"Chronic mucocutaneous candidiasis, a case study and literature review","volume":"28","author":"Khosravi","year":"2018","journal-title":"J. Mycol. Med."},{"key":"10.1016\/j.ejps.2020.105323_bib0024","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(02)08162-X","article-title":"Antifungal drug resistance of pathogenic fungi","volume":"359","author":"Kontoyiannis","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2020.105323_bib0025","series-title":"Stiehm's Immune Deficiencies","first-page":"775","article-title":"Mucocutaneous candidiasis","author":"Mar\u00f3di","year":"2014"},{"key":"10.1016\/j.ejps.2020.105323_bib0026","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity mechanisms","volume":"4","author":"Mayer","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.ejps.2020.105323_bib0027","series-title":"Proceedings of the MATEC Web of Conferences","first-page":"01013","article-title":"Formulation and characterization of nanoemulgel mangosteen extract in virgin coconut oil for topical formulation","author":"Mulia","year":"2018"},{"key":"10.1016\/j.ejps.2020.105323_bib0028","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejps.2009.12.004","article-title":"Preparation and in vitro\u2013in vivo evaluation of witepsol\u00ae H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q10","volume":"39","author":"Nepal","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105323_bib0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-micro-091014-104330","article-title":"Candida albicans biofilms and human disease","volume":"69","author":"Nobile","year":"2015","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ejps.2020.105323_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118629","article-title":"Multi-dose oral abuse deterrent formulation of loperamide using hot melt extrusion","volume":"569","author":"Nukala","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105323_bib0031","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1208\/s12249-019-1298-y","article-title":"Abuse deterrent immediate release egg-shaped tablet (Egglets) using 3D printing technology: quality by design to optimize drug release and extraction","volume":"20","author":"Nukala","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2020.105323_bib0032","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jac\/31.4.463","article-title":"Resistance of yeasts to azole-derivative antifungals","volume":"31","author":"Odds","year":"1993","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.ejps.2020.105323_bib0033","doi-asserted-by":"crossref","first-page":"e21892","DOI":"10.1002\/jbt.21892","article-title":"In vitro assessment of the growth and plasma membrane H(+) -ATPase inhibitory activity of Ebselen and structurally related selenium- and sulfur-containing compounds in candida albicans","volume":"31","author":"Orie","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejps.2020.105323_bib0034","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2018.11.062","article-title":"Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen","volume":"556","author":"Palekar","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105323_bib0035","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/03639045.2018.1546311","article-title":"Development of a solid supersaturated self-nanoemulsifying preconcentrate (S-superSNEP) of fenofibrate using dimethylacetamide and a novel co-processed excipient","volume":"45","author":"Patki","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2020.105323_bib0036","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/0377-4929.94861","article-title":"Antifungal susceptibility testing of candida tropicalis biofilms against fluconazole using calorimetric indicator resazurin","volume":"55","author":"Punithavathy","year":"2012","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1016\/j.ejps.2020.105323_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105039","article-title":"BRD4 protac as a novel therapeutic approach for the treatment of vemurafenib resistant melanoma: preformulation studies, formulation development and in vitro evaluation","volume":"138","author":"Rathod","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105323_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/3647801","article-title":"Anti-inflammatory activity of babassu oil and development of a microemulsion system for topical delivery","volume":"2017","author":"Reis","year":"2017","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.ejps.2020.105323_bib0039","doi-asserted-by":"crossref","first-page":"46915","DOI":"10.1002\/app.46915","article-title":"Soluplus solutions as thermothickening materials for topical drug delivery","volume":"136","author":"Salah","year":"2019","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.ejps.2020.105323_bib0040","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0306-3623(95)00003-J","article-title":"Molecular actions of Ebselen\u2014an antiinflammatory antioxidant","volume":"26","author":"Schewe","year":"1995","journal-title":"Gen. Pharmacol. Vasc. Syst."},{"key":"10.1016\/j.ejps.2020.105323_bib0041","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4161\/derm.1.4.9501","article-title":"Nanoparticles and their interactions with the dermal barrier","volume":"1","author":"Schneider","year":"2009","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.ejps.2020.105323_bib0042","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(04)17107-9","article-title":"Superficial fungal infections","volume":"364","author":"Schwartz","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2020.105323_bib0043","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijpharm.2017.04.068","article-title":"Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs","volume":"526","author":"Sengupta","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105323_bib0044","first-page":"801820","article-title":"Lipid-based drug delivery systems","volume":"2014","author":"Shrestha","year":"2014","journal-title":"J. Pharm. Cairo"},{"issue":"8","key":"10.1016\/j.ejps.2020.105323_bib0047","doi-asserted-by":"crossref","first-page":"a019802","DOI":"10.1101\/cshperspect.a019802","article-title":"Fungi on the skin: dermatophytes and malassezia","volume":"4","author":"White","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejps.2020.105323_bib0048","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.colsurfb.2016.10.013","article-title":"Novel self-assembled tacrolimus nanoparticles cross-linking thermosensitive hydrogels for local rheumatoid arthritis therapy","volume":"149","author":"Wu","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejps.2020.105323_bib0049","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1021\/acschembio.7b00728","article-title":"Ebselen: mechanisms of glutamate dehydrogenase and glutaminase enzyme inhibition","volume":"12","author":"Yu","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejps.2020.105323_bib0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/wnan.1211","article-title":"Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases","volume":"5","author":"Zhang","year":"2013","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720301123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720301123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:52:16Z","timestamp":1760529136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720301123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":48,"alternative-id":["S0928098720301123"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105323","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ebselen nanoemulgel for the treatment of topical fungal infection","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105323"}}